샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774708

세계의 화학, 제조 및 제어 서비스 아웃소싱 시장

Chemistry, Manufacturing and Control Services Outsourcing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 387 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 화학, 제조 및 제어 서비스 아웃소싱 시장은 2030년까지 140억 달러에 이를 전망

2024년에 100억 달러로 추정되는 화학, 제조 및 제어 서비스 아웃소싱 세계 시장은 2024-2030년간 CAGR 5.9%로 성장하여 2030년에는 140억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 API 유형은 CAGR 6.7%를 나타내고, 분석 기간 종료시에는 76억 달러에 이를 것으로 예측됩니다. 완성 의약품 제제 부문의 성장률은 분석 기간중 CAGR 5.3%로 추정됩니다.

미국 시장은 27억 달러로 추정, 중국은 CAGR 9.4%로 성장 예측

미국의 화학, 제조 및 제어 서비스 아웃소싱 시장은 2024년에는 27억 달러에 이를 것으로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 29억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 2.8%와 5.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%로 성장할 전망입니다.

세계의 화학, 제조 및 제어 서비스 아웃소싱 시장 - 주요 동향과 촉진요인 정리

CMC 서비스 아웃소싱 수요가 증가하는 이유

의약품 개발 및 규제 준수 복잡화, CMC 서비스 아웃소싱 수요를 촉진하고 있습니다. 제약회사와 생명공학 기업들은 품질과 안전성 기준을 확보하면서 의약품 승인까지 걸리는 기간을 단축해야 한다는 압박에 직면하고 있습니다. 그 결과, CMC 서비스 아웃소싱이 전략적 솔루션으로 부상하고 있으며, 기업들은 신약개발, 상품화 등 핵심 역량으로 집중하는 한편, 제조 및 관리 프로세스를 전문 제3자 제공업체에 맡길 수 있게 되었습니다. 또한, 생물학적 제제 바이오시밀러,바이오시밀러,개인화 의료의 보급으로 인해 제조 및 품질 관리가 더욱 복잡해지고 있습니다. 이러한 치료법에서는 엄격한 밸리데이션, 분석 특성 평가, 적정 제조 규범(GMP)의 준수가 요구되고 있으며, 개발 및 제조수탁기관(CDMO)에 대한 의존도가 높아지고 있습니다. 또한 비용 효율성과 위험 감소는 인프라에 대한 설비투자를 최소화하고 규제의 복잡성을 줄이기 위해 제약기업이 CMC 서비스를 아웃소싱하는 것이 큰 요인으로 작용하고 있습니다.

기술이 CMC 서비스 아웃소싱을 어떻게 변화시킬 것인가?

고급 분석, 인공지능(AI), 자동화의 통합은 효율성을 높이고, 프로세스의 실패의 가능성을 감소시킴으로써,CMC 서비스 아웃소싱에 AI가 주도하는 예측의 혁명을 일으키고 있습니다. 모델링은 제조 워크플로우 최적화, 품질 관리 개선, 규제 문서 강화에 활용되고 있습니다. 이를 통해 일괄 출시의 신속화 제조 시 편차 감소, 제품 일관성 향상으로 실현하고 있습니다. 또 하나의 중요한 기술적 진보는 실시간 모니터링 및 디지털 트윈 기술 입니다. 이러한 기술 혁신을 통해 생산 공정의 원격 모니터링이 가능하여 전 세계 규제 기준 준수를 보장합니다. 또한, 연속 제조 기술 및 일회용 바이오프로세싱 시스템의 제조 기술 및 데이터 기반 인사이트가 부상함에 따라 CMC 아웃소싱은 바이오제약 기업에게 보다 확장 가능하고 비용 효율적인 방식으로 변화하고 있습니다. 데이터 기반 인사이트가 확산됨에 따라 기업은 제품 품질과 규제 준수를 최적화하기 위해 정보에 입각한 의사결정을 내릴 수 있게 됐습니다.

CMC 아웃소싱의 성장을 주도하는 산업은?

의약품 및 생명공학 부서가 CMC 아웃소싱의 주요 촉진요인이며, 신규 치료제, 백신, 바이오시밀러의 개발에 점점 더 집중하고 있습니다. 또한, 세포 치료 및 유전자 치료 수요도 증가하고 있으며, 이러한 첨단 치료법에 필요한 복잡한 제형, 안정성 시험, 공정 최적화 화를 관리하기 위한 전문 CMC 서비스 필요하고 있습니다. 또한 의약품 개발 수탁기관(CRO) 및 CDMO는 사내에 제조 전문 지식이 없는 신생 제약기업을 지원하기 위해 그 역량을 확장하고 있습니다. 재생의료, 맞춤치료제, 고역가 의약품도. 재생의료, 개인맞춤형 치료제, 고역가 의약품도 특수 CMC 프로토콜과 엄격한 세계 규제 준수를 위해 필요하기 때문에 시장 성장에 기여하고 있습니다. FDA, EMA, 기타 규제 기관의 긴장이 고조되면서 제3자의 CMC 전문 지식의 필요성이 더욱 커지고 있습니다.

시장 성장 요인은 무엇인가?

화학 제조 및 관리(CMC) 서비스 및 아웃소싱 시장의 성장은 연구개발 투자 증가 등 몇 가지 요인에 의해 촉진되고 있습니다. 제약회사는 분석 법 개발, 안정성 시험, 제형 최적화, 대규모 GMP 제조 등 종합적인 솔루션 제공할 수 있는 아웃소싱 파트너를 적극적으로 찾고 있습니다. 또한 아시아태평양의 신흥 시장은 기업이 이 지역의 비용 효율적인 제조 능력과 숙련된 노동력을 활용하면 활용함으로써, CMC 서비스 아웃소싱 확장에 매우 중요한 역할을 하고 있습니다. 또한, 클라우드 기반의 품질관리시스템(QMS) )의 채용이 진행됨에 따라, CMC 컴플라이언스가 제약회사와 아웃소싱 파트너의 원활한 협업을 가능하게 합니다. 바이오의약품의 기술 혁신, 자동화, 규제준수의 진전에 함께,CMC 서비스 아웃소싱 시장은 향후 몇 년 동안 강력한 성장을 이룰 것으로 예측됩니다.

부문

제품 유형(원료의약품 유형, 최종 제제 유형, 기타 유형), 서비스 유형(제조 서비스, 약사 서비스, 분석 시험 서비스, 기타 서비스), 최종사용자(제약 기업 최종사용자, 바이오테크놀러지 기업 최종사용자, 의료기기 기업 최종사용자, 기타 최종사용자)

조사 대상 기업 예

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma
  • Allucent
  • Ardena Holding NV
  • Argonaut Manufacturing Services Inc.
  • Bachem
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • Charles River Laboratories
  • CordenPharma
  • Evonik Industries AG
  • ICON plc
  • Jubilant Life Sciences
  • Pace Analytical Services
  • Recipharm AB
  • Samsung Biologics
  • SGS(Societe Generale de Surveillance)
  • Siegfried Holding AG
  • Thermo Fisher Scientific
  • WuXi AppTec

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.29

Global Chemistry, Manufacturing and Control Services Outsourcing Market to Reach US$14.0 Billion by 2030

The global market for Chemistry, Manufacturing and Control Services Outsourcing estimated at US$10.0 Billion in the year 2024, is expected to reach US$14.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. API Type, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Finished Drug Formulation segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 9.4% CAGR

The Chemistry, Manufacturing and Control Services Outsourcing market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Chemistry, Manufacturing and Control Services Outsourcing Market - Key Trends & Drivers Summarized

Why is the Demand for CMC Services Outsourcing Increasing?

The increasing complexity of drug development and regulatory compliance is driving the demand for CMC services outsourcing. Pharmaceutical and biotech companies are facing heightened pressure to accelerate drug approval timelines while ensuring quality and safety standards. As a result, outsourcing CMC services has emerged as a strategic solution, allowing companies to focus on core competencies such as drug discovery and commercialization while delegating manufacturing and control processes to specialized third-party providers. Moreover, the growing prevalence of biologics, biosimilars, and personalized medicine has made manufacturing and quality control more intricate. These therapies require rigorous validation, analytical characterization, and compliance with Good Manufacturing Practices (GMP), increasing the reliance on contract development and manufacturing organizations (CDMOs). Additionally, cost-efficiency and risk mitigation are major factors compelling pharmaceutical firms to outsource CMC services, as it minimizes capital investment in infrastructure and reduces regulatory complexities.

How is Technology Transforming CMC Services Outsourcing?

The integration of advanced analytics, artificial intelligence (AI), and automation is revolutionizing CMC services outsourcing by enhancing efficiency and reducing the likelihood of process failures. AI-driven predictive modeling is being used to optimize manufacturing workflows, improve quality control, and enhance regulatory documentation. This has led to faster batch release, reduced variability in production, and improved product consistency. Another key technological advancement is real-time monitoring and digital twin technology. These innovations enable remote oversight of production processes, ensuring compliance with global regulatory standards. Additionally, the rise of continuous manufacturing techniques and single-use bioprocessing systems is transforming CMC outsourcing, making it more scalable and cost-effective for biopharmaceutical companies. As data-driven insights become more prevalent, companies are able to make informed decisions that optimize product quality and regulatory adherence.

Which Industries Are Driving the Growth of CMC Outsourcing?

The pharmaceutical and biotechnology sectors are the primary drivers of CMC outsourcing, with an increasing focus on developing novel therapeutics, vaccines, and biosimilars. The demand for cell and gene therapies is also rising, necessitating specialized CMC services to manage the complex formulation, stability testing, and process optimization required for these advanced treatments. In addition, contract research organizations (CROs) and CDMOs are expanding their capabilities to support emerging pharmaceutical firms that lack in-house manufacturing expertise. Regenerative medicine, personalized therapeutics, and high-potency drugs are also contributing to market growth, as these require specialized CMC protocols and compliance with stringent global regulations. The growing stringency of FDA, EMA, and other regulatory agencies is further reinforcing the need for third-party CMC expertise.

What Factors Are Fueling Market Growth?

The growth in the Chemistry, Manufacturing and Control (CMC) Services Outsourcing market is driven by several factors, including rising R&D investments, growing regulatory scrutiny, and increasing demand for complex biologics and specialty drugs. Pharmaceutical companies are actively seeking outsourcing partners that can provide comprehensive solutions for analytical method development, stability studies, formulation optimization, and large-scale GMP production. Additionally, emerging markets in Asia-Pacific are playing a pivotal role in the expansion of CMC services outsourcing, as companies leverage the region's cost-effective manufacturing capabilities and skilled workforce. The increasing adoption of cloud-based quality management systems (QMS) is also streamlining CMC compliance, enabling seamless collaboration between pharma companies and outsourcing partners. With ongoing advancements in biopharmaceutical innovation, automation, and regulatory compliance, the CMC services outsourcing market is poised for robust growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Chemistry, Manufacturing and Control Services Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (API Type, Finished Drug Formulation, Other Types); Service Type (Manufacturing Services, Regulatory Services, Analytical Testing Services, Other Services); End-Use (Pharmaceutical Companies End-Use, Biotechnological Companies End-Use, Medical Device Companies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • AbbVie Inc.
  • Ajinomoto Bio-Pharma
  • Allucent
  • Ardena Holding NV
  • Argonaut Manufacturing Services Inc.
  • Bachem
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • Charles River Laboratories
  • CordenPharma
  • Evonik Industries AG
  • ICON plc
  • Jubilant Life Sciences
  • Pace Analytical Services
  • Recipharm AB
  • Samsung Biologics
  • SGS (Societe Generale de Surveillance)
  • Siegfried Holding AG
  • Thermo Fisher Scientific
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Chemistry, Manufacturing and Control Services Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expansion of Biologics and Cell & Gene Therapy Pipelines Drives Outsourcing Demand
    • Growing Complexity of Drug Modalities Strengthens Need for Specialized CMC Expertise
    • Cost Optimization and Faster Time-to-Market Propel Outsourcing of CMC Operations
    • Increased Adoption of Modular and Continuous Manufacturing Supports Agile Development
    • Outsourcing Demand Fueled by Small and Virtual Biopharma Companies
    • Expansion of Global CDMO Footprints Enhances Access to Regional Regulatory Know-How
    • Digitalization and Automation of CMC Workflows Improve Data Integrity and Reproducibility
    • Rise in Phase-Appropriate CMC Strategies Supports Early-Stage Development Programs
    • Focus on Analytical Method Development and Validation Enhances Quality Assurance
    • Growth in High-Potency API Production Requires Specialized CMC Infrastructure
    • Strategic Partnerships Between Sponsors and Service Providers Drive Long-Term Value
    • Use of Integrated CMC Platforms Streamlines Technology Transfer and Scale-Up
    • Demand for Accelerated IND/CTA Filing Drives Rapid CMC Package Development
    • Increased Emphasis on Tech-Enabled Project Management Enhances Collaboration
    • Expansion of Biotech Funding and IPO Activity Sustains Long-Term Outsourcing Trends
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Chemistry, Manufacturing and Control Services Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for API Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for API Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for API Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Finished Drug Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Finished Drug Formulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Finished Drug Formulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biotechnological Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biotechnological Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biotechnological Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Manufacturing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Manufacturing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Regulatory Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Analytical Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Analytical Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Analytical Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • JAPAN
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • CHINA
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • EUROPE
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • FRANCE
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • GERMANY
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • INDIA
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030
  • AFRICA
    • Chemistry, Manufacturing and Control Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - API Type, Finished Drug Formulation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Product Type - Percentage Breakdown of Value Sales for API Type, Finished Drug Formulation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Other End-Uses, Pharmaceutical Companies End-Use and Biotechnological Companies End-Use for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Chemistry, Manufacturing and Control Services Outsourcing by Service Type - Percentage Breakdown of Value Sales for Manufacturing Services, Regulatory Services, Analytical Testing Services and Other Services for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제